EXAS logo Exact Sciences : EXAS

EXAS

Stock Data

$102.43

Change up

$0.09 (0.09%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DIAGNOSTICS & RESEARCH

Exact Sciences Corp specializes in cancer screening and diagnostic tests, offering innovative solutions like Cologuard, a non-invasive test for colorectal cancer detection. Beyond colorectal health, it provides Oncotype DX tests for breast and colon cancer recurrence, and the OncoExTra Test for advanced cancers. The company is also involved in COVID-19 testing and is working on developing new blood and fluid-based tests for cancer detection. Founded in 1995 and based in Madison, Wisconsin, Exact Sciences continues to expand its diagnostic portfolio through partnerships with leading research institutions.

All Exact Sciences Articles

28 Articles

1 2